News Release

Association of receipt of fourth Pfizer-BioNTech vaccine dose with Omicron infection, COVID-19 hospitalizations among residents of long-term care facilities

JAMA Internal Medicine

Peer-Reviewed Publication

JAMA Network

About The Study: The results of this study suggest that receipt of a fourth dose of the Pfizer-BioNTech vaccine conferred high protection against COVID-19 hospitalizations and deaths among long-term care facility residents in Israel during a substantial Omicron variant surge but protection was modest against infection.

Authors: Khitam Muhsen, Ph.D., of Tel Aviv University in Tel Aviv, Israel, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link


Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.